COT-31 Risk Factors for the Development of Skin Rash with Levetiracetam and Lacosamide in Patients with Glioma

Introduction: Seizure control of in glioma patients is essential for quality of life. The new generation anti-seizure drug (ASD) is represented by lacosamide (LCM) and levetiracetam (LEV), and is said to have few side effects of eruption. We retrospectively analyzed the incidence of rash and related...

Descripción completa

Detalles Bibliográficos
Autores principales: Onodera, Mikoto, Muragaki, Yoshihiro, Fukui, Atsushi, Nitta, Masayuki, Saito, Taiichi, Tsuzuki, Syunsuke, Kooriyama, Syunichi, Tamura, Manabu, Kimura, Toshimi, Kawamata, Takakazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648194/
http://dx.doi.org/10.1093/noajnl/vdab159.123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648194/
http://dx.doi.org/10.1093/noajnl/vdab159.123

Ejemplares similares